Form 4: Perrigo Executive Robert Willis Reports Stock Transactions

EVP & CHRO of Perrigo, Robert Willis, reports acquisition and disposal of ordinary shares and restricted stock units.

Summary

• Robert Willis, EVP & CHRO of Perrigo Company plc, filed a Form 4 detailing changes in beneficial ownership.
• On March 6, 2024, Willis acquired 1,759 ordinary shares at $28.09 through the vesting of restricted stock units and disposed of 915 shares at $28.09.
• On March 7, 2024, Willis acquired 2,163 ordinary shares at $29.69 through the vesting of restricted stock units and disposed of 1,125 shares at $29.69.
• Following these transactions, Willis directly owns 31,470 ordinary shares and 2,163 restricted stock units.

Sentiment

Score: 6

Explanation: Neutral sentiment as the transactions are routine and related to executive compensation. The disposal of shares is not significant enough to indicate a negative outlook.

Positives

• The vesting of restricted stock units indicates a form of compensation and alignment of executive interests with shareholder value.

Negatives

• The disposal of shares could be interpreted negatively, although it may be for tax purposes related to the vesting of restricted stock units.

Risks

• Executive stock transactions can sometimes be misinterpreted by the market, leading to short-term price volatility.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's performance and future prospects.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units that vest over time, aligning executive interests with long-term shareholder value, similar to practices at companies like Teva and Mylan.
• Form 4 filings are standard practice and are comparable to those of executives at similar pharmaceutical companies.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are part of standard executive compensation practices.

Key Dates